A recent scientific investigation has uncovered that serotonin, the neurotransmitter most commonly associated with mood regulation, might likewise influence the perceived severity of tinnitus. The findings of this study have been published in the Proceedings of the National Academy of Sciences.
According to the research, conducted on mice by scientists from both the United States and China, an escalation in serotonin signaling within a particular neural circuit in the brain resulted in intensified behavioral responses linked to this neurological affliction.
Given that serotonin is frequently employed to alleviate symptoms of both depression and anxiety, this discovery holds the potential to guide the creation of therapeutic interventions that ease these conditions without exacerbating tinnitus.
“We had an inkling that serotonin was involved in the onset of tinnitus, but the exact mechanism remained elusive. Now, by utilizing mice, we have identified a specific serotonin-linked neural pathway in the brain that directly impinges upon the auditory system, and we discerned that it can induce effects mirroring those of tinnitus,” states neurobiologist Zheng-Quan Tang from Anhui University in China. “When we inhibited this circuit, we were able to substantially reduce the tinnitus symptoms. This grants us a much clearer picture of intracerebral happenings and points toward novel avenues for treatment.”
Tinnitus is typically characterized as a “phantom” sound audible solely to the afflicted individual, frequently presenting as a high-pitched ringing, hissing, buzzing, or pulsing noise. While some underlying causes are known, such as hearing impairment or earwax buildup, in many instances, it appears to stem from a neurological issue originating not in the ear itself, but within the brain’s auditory system.
Describing the unrelenting distress caused by the constant disturbance of the auditory system is challenging, yet numerous patients concurrently report experiences of depression, anxiety, and suicidal ideation. Managing these mood disorders often involves administering medications known as selective serotonin reuptake inhibitors (SSRIs), which function by blocking the reabsorption of serotonin by neurons, thereby increasing serotonin signal transmission.
Over the past several decades, numerous studies have hinted at a connection between serotonin and tinnitus; however, concrete proof of this linkage and its underlying mechanism remained absent until now. To explore this mechanism, the researchers designed an experiment utilizing mice.
Initially, they mapped the projection tract running from the dorsal raphe nucleus—a brainstem region responsible for serotonin production—to the dorsal cochlear nucleus, an auditory processing center. This pathway plays a role in modulating how the brain interprets incoming sound signals.
Subsequently, they genetically engineered the mice to allow for the activation of serotonin-releasing neurons within the dorsal raphe nucleus via light exposure or pharmaceutical agents.
Mice with activated serotonergic circuits, alongside a control group, were then subjected to several testing paradigms to determine if their behavior suggested the perception of a subjective sound.
One of the most telling indicators was the mice’s inability to distinguish silences embedded within auditory stimuli—a widely adopted technique in animal studies to model tinnitus perception.
“When we stimulate these serotonergic neurons, we observe that this provokes activity within the auditory sector of the brain,” notes neurobiologist Lawrence Trussel from Oregon Health & Science University. “We also noted that the animals behaved as if they were hearing tinnitus. In essence, it generated the symptoms we would anticipate observing in humans experiencing ringing in the ears.”
When inhibitory agents were applied to completely silence this serotonergic-auditory pathway, the mice’s tinnitus-like behavior diminished. Furthermore, when loud noise was used to deliberately induce tinnitus, the mice exhibited a behavioral pattern mirroring that observed when serotonin activity was artificially boosted.
These findings suggest that the link between serotonin and tinnitus is authentic, and this specific brain circuit might play a direct role in generating the phantom sounds experienced by patients, necessitating further clinical investigation in humans.
This also implies that managing comorbid depression or anxiety alongside tinnitus requires a judicious and careful therapeutic approach.
“Our research points toward a delicate equilibrium,” remarks Trussel. “It may be possible to engineer pharmaceuticals that target specific cells or brain regions to modulate elevated serotonin levels in some areas while leaving others unaffected. This way, the beneficial and essential effects of an antidepressant could be decoupled from any potentially detrimental consequences to hearing.”
About the Author
